Scancell Company
Scancell is focused on developing innovative immunotherapies for cancer that stimulate the body’s own immune system.
Headquarters:
Nottingham, Nottingham, United Kingdom
Employee Number:
11-50
Founded Date:
1996
Investment Stage:
N/A
Technology:
Drug Discovery
Investor Type:
N/A
Number Of Exists:
N/A
Industry:
Personalized Medicine
Funding Status:
IPO